Oncostatin M is expressed in atherosclerotic lesions: A role for Oncostatin M in the pathogenesis of atherosclerosis (Q53263233)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 3, 2011

Language	Label	Description	Also known as
English	Oncostatin M is expressed in atherosclerotic lesions: A role for Oncostatin M in the pathogenesis of atherosclerosis	scientific article published on March 3, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

Oncostatin M is expressed in atherosclerotic lesions: A role for Oncostatin M in the pathogenesis of atherosclerosis (English)

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Adaia Albasanz-Puig

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

Jacqueline Murray

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

Michael Preusch

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

Daniel Coan

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

Mayumi Namekata

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

Yatin Patel

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

Zhao Ming Dong

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

Michael E. Rosenfeld

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21376322

26 November 2024

Errol S. Wijelath

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21376322

26 November 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21376322

26 November 2024

publication date

3 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

full work available at URL

https://api.elsevier.com/content/article/PII:S0021915011001195?httpAccept=text/xml

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

https://api.elsevier.com/content/article/PII:S0021915011001195?httpAccept=text/plain

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

216

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

292-298

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

Inflammation in atherosclerosis: from pathophysiology to practice

1

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Thematic review series: The immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease.

2

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Molecular regulation of vascular smooth muscle cell differentiation in development and disease

3

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells

4

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis

5

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury

6

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Roles of IL-6-gp130 Signaling in Vascular Inflammation

7

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Neuropoietic cytokines in the hematopoietic fold

8

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Oncostatin M promotes biphasic tissue factor expression in smooth muscle cells: evidence for Erk-1/2 activation

9

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammation.

10

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells

12

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages

13

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

15

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Evidence for a differential expression of fibronectin splice forms ED-A and ED-B in Crohn's disease (CD) mucosa.

16

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Expression of vascular endothelial growth factor receptors in smooth muscle cells

17

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis

18

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries

19

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology

20

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques

21

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules

22

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events

23

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study

24

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

The inflammatory mediator oncostatin M induces angiopoietin 2 expression in endothelial cells in vitro and in vivo

26

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Oncostatin M induces angiogenesis in vitro and in vivo

27

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways

29

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells : synergy with interleukin-1beta

30

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta

31

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

New insights into form and function of fibronectin splice variants

32

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Balloon catheterization induced arterial expression of embryonic fibronectins.

33

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent

34

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis

35

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Pharmaceutical intervention in the JAK/STAT signaling pathway

36

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling.

37

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

38

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis

39

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells

40

1 reference

10.1016/J.ATHEROSCLEROSIS.2011.02.003

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2011.02.003

26 November 2024

Identifiers

10.1016/J.ATHEROSCLEROSIS.2011.02.003

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21376322

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53263233&oldid=2279947197"